Sine causa tetraparesis

Autor: Giulio Gualdi, Luisa Lorenzi, Gillian I. Rice, Jessica Galli, Donatella Vairo, Marzia Mortilla, Fabio Facchetti, Marco Cattalini, Francesco Gavazzi, Marika Bianchi, Cristina Cereda, Silvia Giliani, Antonella Meini, Elisa Fazzi, Alessandra Zanola, Micaela De Simone, Raffaele Badolato, Micaela Fredi, Rosalba Monica Ferraro, Nice Carabellese, Laura Andreoli, Marialuisa Valente, Simona Orcesi, Jessica Garau, Angela Tincani
Rok vydání: 2018
Předmět:
Male
0301 basic medicine
Pathology
medicine.medical_specialty
Adolescent
Encephalopathy
Pilot Projects
Tetraparesis
Nervous System Malformations
Diagnostic Accuracy Study
Cerebral palsy
Young Adult
03 medical and health sciences
Autoimmune Diseases of the Nervous System
0302 clinical medicine
medicine
Humans
Medical history
Preschool
Child
Aicardi-goutières syndrome
Interferon signature
Interferonopathy
Biomarkers
Brain
Child
Preschool

Female
Interferon Type I
Magnetic Resonance Imaging
Paresis
medicine.diagnostic_test
tetraparesis
business.industry
aicardi–goutières syndrome
interferonopathy
Magnetic resonance imaging
General Medicine
medicine.disease
030104 developmental biology
interferon signature
Etiology
Spastic tetraparesis
Aicardi–Goutières syndrome
business
030217 neurology & neurosurgery
Research Article
Zdroj: AGS study group 2018, ' Sine causa tetraparesis : A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis ', Medicine (Philadelphia), vol. 97, no. 52, pp. e13893 . https://doi.org/10.1097/MD.0000000000013893
Medicine
ISSN: 1536-5964
0025-7974
DOI: 10.1097/md.0000000000013893
Popis: Tetraparesis is usually due to cerebral palsy (CP), inborn errors of metabolism, neurogenetic disorders and spinal cord lesions. However, literature data reported that about 10% of children with tetraparesis show a negative/non-specific neuroradiological findings without a specific etiological cause. Aicardi Goutières Syndrome (AGS) is a genetic encephalopathy that may cause tetraparesis. Interferon signature is a reliable biomarker for AGS and could be performed in sine-causa tetraparesis. The aim of the study was to examine the type I interferon signature and AGS related-genes in children with sine causa tetraparesis, to look for misdiagnosed AGS. A secondary aim was to determine which aspects of the patient history, clinical picture and brain imaging best characterize tetraparesis due to an interferonopathy. Seven out of 78 patients affected by tetraparesis, characterized by unremarkable pre-peri-postnatal history and normal/non-specific brain magnetic resonance imaging (MRI) were selected and underwent anamnestic data collection, clinical examination, brain imaging review, peripheral blood interferon signature and AGS-related genes analysis. At our evaluation time (mean age of 11.9 years), all the 7 patients showed spastic-dystonic tetraparesis. At clinical onset brain MRI was normal in 4 and with non-specific abnormalities in 3; at follow-up 3 patients presented with new white-matter lesions, associated with brain calcification in 1 case. Interferon signature was elevated in one subject who presented also a mutation of the IFIH1 gene. AGS should be considered in sine-causa tetraparesis. Core features of interferonopathy-related tetraparesis are: onset during first year of life, psychomotor regression with tetraparesis evolution, brain white-matter lesions with late calcifications. A positive interferon signature may be a helpful marker to select patients with spastic tetraparesis who should undergo genetic analysis for AGS.
Databáze: OpenAIRE